Figure 5

Prediction of treatment response using Ktrans from dynamic contrast-enhanced MRI. By using Ktrans, tumor volumes (V), prostate-specific antigen (PSA) and treatment groups as inputs to the back propagation neural network (BPNN) a correlation coefficient of 0.66 (p < 0.001) was found between predicted and measured treatment response (V30).